Information Journal Paper
APA:
CopyGURNANI, M., LIPARI, P., DELL, J., SHI, B., & NIELSEN, L.L.. (1999). ADENOVIRUS MEDIATED P53 GENE THERAPY HAS GREATER EFFICACY WHEN COMBINED WITH CHEMOTHERAPY AGAINST HUMAN HEAD AND NECK, OVARIAN, PROSTATE, AND BREAST CANCER. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 44(-), 143-151. SID. https://sid.ir/paper/543297/en
Vancouver:
CopyGURNANI M., LIPARI P., DELL J., SHI B., NIELSEN L.L.. ADENOVIRUS MEDIATED P53 GENE THERAPY HAS GREATER EFFICACY WHEN COMBINED WITH CHEMOTHERAPY AGAINST HUMAN HEAD AND NECK, OVARIAN, PROSTATE, AND BREAST CANCER. CANCER CHEMOTHERAPY AND PHARMACOLOGY[Internet]. 1999;44(-):143-151. Available from: https://sid.ir/paper/543297/en
IEEE:
CopyM. GURNANI, P. LIPARI, J. DELL, B. SHI, and L.L. NIELSEN, “ADENOVIRUS MEDIATED P53 GENE THERAPY HAS GREATER EFFICACY WHEN COMBINED WITH CHEMOTHERAPY AGAINST HUMAN HEAD AND NECK, OVARIAN, PROSTATE, AND BREAST CANCER,” CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol. 44, no. -, pp. 143–151, 1999, [Online]. Available: https://sid.ir/paper/543297/en